2型糖尿病缓解:非手术随机对照试验的系统综述与荟萃分析
该系统综述与荟萃分析纳入18项来自11个国家的非手术随机对照试验,评估多模式药物或非药物干预对成人2型糖尿病缓解的效果。结果显示,与对照组相比,多模式干预(RR 1.75,95%CI 1.49-2.04)和非药物干预(RR 5.80,95%CI 4.28-7.87)均显著提高2型糖尿病缓解可能性,并在糖化血红蛋白、体重、生活质量及低血糖不良事件方面有改善。
要点
- 多模式干预可提高2型糖尿病缓解率,RR为1.75(95%CI 1.49-2.04)。
- 非药物干预的缓解效应更显著,RR为5.80(95%CI 4.28-7.87)。
- 干预还改善糖化血红蛋白、体重、生活质量及低血糖不良事件。
核心结论
- 在特定方案下,多种定制化方法可诱导新诊断且能严格遵循方案的2型糖尿病患者实现缓解。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Embase(从建库至2025年4月),纳入18项非手术随机对照试验,来自11个国家。
主要发现
- 与对照组相比,多模式干预的2型糖尿病缓解风险比(RR)为1.75(95%CI 1.49-2.04)。
- 非药物干预的缓解RR为5.80(95%CI 4.28-7.87)。
- 干预组在糖化血红蛋白变化、体重减轻、生活质量及低血糖不良事件方面有显著改善。
临床怎么用
- 对于新诊断且能严格遵循特定方案的2型糖尿病患者,可考虑采用多模式或非药物干预以诱导缓解。
局限性
- 纳入研究数量少且存在异质性(非药物组分多样)。
- 干预方案严格,参与者选择标准狭窄。
- 糖尿病缓解定义缺乏一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence that type 2 diabetes can be reversed has been limited by the understanding and implementation of these interventions. PURPOSE: We assessed the effect of nonsurgical randomized controlled trials (RCTs) on type 2 diabetes remission and characterized core components. DATA SOURCES: We reviewed articles from MEDLINE and Embase (inception to April 2025). STUDY SELECTION: RCTs of multimodal pharmacological or nonpharmacological type 2 diabetes remission interventions for adults with type 2 diabetes were included. DATA EXTRACTION: Study characteristics and outcomes for clinical/population health, patient-reported, and adverse event were extracted. DATA SYNTHESIS: We performed a random-effects multilevel meta-analysis of studies, grouped based on type of intervention and by length of follow-up. A total of 18 studies were included in this review from 11 different countries. There was a higher likelihood of achieving type 2 diabetes remission through multimodal interventions (risk ratio [RR] 1.75 [95% CI 1.49-2.04]) and for nonpharmacological interventions (RR 5.80 [95% CI 4.28-7.87]), compared with the control group. Other significant outcomes for intervention groups compared with control groups included change in A1C, weight loss, and quality of life and improvements in adverse events of hypoglycemia. LIMITATIONS: There was heterogeneity in our small pool of included studies (diversity of nonpharmacological components), stringent intervention protocols, narrow participant selection criteria, and lack of consistent diabetes remission definitions. CONCLUSIONS: With specific protocols, a variety of tailored approaches can induce type 2 diabetes remission for patients with newly diagnosed type 2 diabetes who are able to subscribe to strict protocols. Consideration of long-term sustainability and effectiveness is needed in future research, along with patient preferences.
引用
- Sherifali DT, Racey ME, Greenway MK, et al. Type 2 Diabetes Remission: A Systematic Review and Meta-analysis of Nonsurgical Randomized Controlled Trials. Diabetes Care. 2025. PMID: 40982327. doi:10.2337/dc25-0562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。